Codetta Bio™ Expands Global Commercial Leadership to Accelerate Worldwide Adoption of the Concerto™ System

Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic acids (RNA and DNA), today announced a significant expansion of its global commercial organization. This strategic move strengthens the company’s ability to meet growing demand for its Concerto™ system as Codetta transitions from its Technology Access Program (TAP) to full commercial launch.